A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing actions

被引:0
|
作者
Gault, V. A. [1 ]
Martin, C. M. [1 ]
Parthsarathy, V. [1 ]
Irwin, N. [1 ]
机构
[1] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
119
引用
收藏
页码:S56 / S57
页数:2
相关论文
共 9 条
  • [1] A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing properties
    Parthsarathy, Vadivel
    Irwin, Nigel
    Hasib, Annie
    Martin, Christine M.
    McClean, Stephen
    Bhat, Vikas K.
    Ng, Ming T.
    Flatt, Peter R.
    Gault, Victor A.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (04): : 757 - 764
  • [2] Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25
    Martin, Christine M. A.
    Gault, Victor A.
    McClean, Stephen
    Flatt, Peter R.
    Irwin, Nigel
    [J]. BIOCHEMICAL PHARMACOLOGY, 2012, 84 (03) : 312 - 319
  • [3] Improved glucose-lowering, insulin-releasing and anorexigenic actions of a novel chemically modified analogue of oxyntomodulin, (D-Ser2)Oxm[mPEG-PAL]
    Gault, V. A.
    Kerr, B. D.
    Flatt, P. R.
    [J]. DIABETOLOGIA, 2010, 53 : S14 - S15
  • [4] A novel analogue of oxyntomodulin with improved glucose-lowering, insulinotropic and anorexigenic actions
    Kerr, B. D.
    Flatt, P. R.
    Gault, V. A.
    [J]. REGULATORY PEPTIDES, 2010, 164 (01) : 33 - 33
  • [5] Insulin-releasing and glucose-lowering properties of a novel hybrid peptide, G-TGN
    Falobi, A. A.
    Ofosu, W. A.
    Edeani, J. N.
    Dunmore, S.
    Smyth, L.
    Corcoran, O.
    Ojo, O. O.
    [J]. DIABETIC MEDICINE, 2023, 40
  • [6] Novel fatty acid derivatised forms of glucose-dependent insulinotropic polypeptide with improved glucose-lowering and insulin-releasing properties
    Gault, V. A.
    Kerr, B. D.
    Irwin, N.
    O'Harte, F. P. M.
    Flatt, P. R.
    [J]. DIABETOLOGIA, 2009, 52 : S309 - S309
  • [7] Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells
    Moran, B. M.
    Abdel-Wahab, Y. H. A.
    Flatt, P. R.
    McKillop, A. M.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (11): : 1128 - 1139
  • [8] A novel GLP-1/glucagon co-agonist peptide exhibits improved glucose-lowering and insulinotropic actions in diet induced obese diabetic mice
    Gault, V. A.
    Bhat, V. K.
    Flatt, P. R.
    [J]. DIABETOLOGIA, 2013, 56 : S400 - S400
  • [9] Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity-diabetes
    Gault, VA
    Flatt, PR
    Bailey, CJ
    Harriott, P
    Greer, B
    Mooney, MH
    O'Harte, FPM
    [J]. BIOCHEMICAL JOURNAL, 2002, 367 : 913 - 920